Stem definition | Drug id | CAS RN |
---|---|---|
halogenated compounds used as general inhalation anaesthetics | 811 | 57041-67-5 |
None
None
Date | Agency | Company | Orphan |
---|---|---|---|
Sept. 18, 1992 | FDA | BAXTER HLTHCARE |
None
None
Source | Code | Description |
---|---|---|
ATC | N01AB07 | NERVOUS SYSTEM ANESTHETICS ANESTHETICS, GENERAL Halogenated hydrocarbons |
FDA PE | N0000175975 | General Anesthesia |
FDA EPC | N0000175681 | General Anesthetic |
MeSH PA | D000777 | Anesthetics |
MeSH PA | D018685 | Anesthetics, Inhalation |
CHEBI has role | CHEBI:38870 | inhalation anaesthetic |
MeSH PA | D002491 | Central Nervous System Agents |
MeSH PA | D002492 | Central Nervous System Depressants |
Disease | Relation | SNOMED_ID | DOID |
---|---|---|---|
General anesthesia | indication | 50697003 | |
Hyperkalemia | contraindication | 14140009 | |
Cirrhosis of liver | contraindication | 19943007 | DOID:5082 |
Viral hepatitis C | contraindication | 50711007 | DOID:1883 |
Viral hepatitis type B | contraindication | 66071002 | DOID:2043 |
Benign intracranial hypertension | contraindication | 68267002 | DOID:11459 |
Duchenne muscular dystrophy | contraindication | 76670001 | DOID:11723 |
Myasthenia gravis | contraindication | 91637004 | DOID:437 |
Disease of liver | contraindication | 235856003 | DOID:409 |
Neuromyopathy | contraindication | 255522009 | DOID:440 |
Familial periodic paralysis | contraindication | 267607008 | DOID:1029 |
Lesion of brain | contraindication | 301766008 | |
Malignant hyperthermia | contraindication | 405501007 | |
Disorder of coronary artery | contraindication | 414024009 |
None
None
None
Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
---|---|---|---|---|---|---|---|---|---|
Glycine receptor (alpha-1/beta) | Ion channel | POSITIVE MODULATOR | CHEMBL | CHEMBL | |||||
GABA-A receptor; anion channel | Ion channel | POSITIVE ALLOSTERIC MODULATOR | CHEMBL | CHEMBL | |||||
Potassium channel subfamily K member 10 | Ion channel | OPENER | CHEMBL | CHEMBL | |||||
Potassium channel subfamily K member 18 | Ion channel | OPENER | CHEMBL | CHEMBL | |||||
Potassium channel subfamily K member 3 | Ion channel | OPENER | CHEMBL | CHEMBL | |||||
Potassium channel subfamily K member 9 | Ion channel | OPENER | CHEMBL | CHEMBL | |||||
Potassium channel subfamily K member 2 | Ion channel | OPENER | CHEMBL | CHEMBL |
ID | Source |
---|---|
D000077335 | MESH_DESCRIPTOR_UI |
4020649 | VUID |
N0000148295 | NUI |
C0063252 | UMLSCUI |
D00546 | KEGG_DRUG |
108393001 | SNOMEDCT_US |
247482 | MMSL |
4020649 | VANDF |
d02374 | MMSL |
4545 | MMSL |
27340 | RXNORM |
386841003 | SNOMEDCT_US |
004114 | NDDF |
CRS35BZ94Q | UNII |
6505 | INN_ID |
42113 | PUBCHEM_CID |
CHEBI:4445 | CHEBI |
CHEMBL1200733 | ChEMBL_ID |
DSF | PDB_CHEM_ID |
DB01189 | DRUGBANK_ID |
7156 | IUPHAR_LIGAND_ID |
Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
---|---|---|---|---|---|---|---|---|
Desflurane | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0781-6172 | LIQUID | 240 mL | RESPIRATORY (INHALATION) | ANDA | 18 sections |
SUPRANE | HUMAN PRESCRIPTION DRUG LABEL | 1 | 10019-641 | LIQUID | 240 mL | RESPIRATORY (INHALATION) | NDA | 18 sections |
Suprane | HUMAN PRESCRIPTION DRUG LABEL | 1 | 10019-644 | LIQUID | 240 mL | RESPIRATORY (INHALATION) | NDA | 18 sections |
SUPRANE | HUMAN PRESCRIPTION DRUG LABEL | 1 | 10019-646 | LIQUID | 240 mL | RESPIRATORY (INHALATION) | NDA | 18 sections |
Suprane | HUMAN PRESCRIPTION DRUG LABEL | 1 | 52584-641 | LIQUID | 240 mL | RESPIRATORY (INHALATION) | NDA | 15 sections |